Abstract PO1-24-04: Gedatolisib, a Pan-Pi3k/mtor Inhibitor, Shows Superior Potency and Efficacy Relative to Other PI3K/AKT/mTOR Pathway Inhibitors in Breast Cancer Models
Cancer research（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined